ST PHARM News — ST PHARM

Science & Technology
- Business Overview
- CDMO
- CRO
  - AnaPath Research & Service
- R&D
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

ST PHARM News

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

ST PHARM's Public Release

ST PHARM NewsST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide FacilitySep 19, 2023

ST PHARM News[Inovation Center Time lapse Movie]Mar 6, 2023

ST PHARM NewsST PHARM participated in 2023 JP Morgan healthcare conferenceJan 4, 2023

ST PHARM NewsST PHARM, 2022 KCGS ESG rating 'B+'Dec 5, 2022

ST PHARM NewsST PHARM, 2022 Sustinvest ESG Rating 'AA'Nov 18, 2022

ST PHARM NewsST PHARM Participated in 10th International mRNA Health ConferenceOct 31, 2022

ST PHARM NewsST PHARM, Participated in CPHI 2022 FrankfrutOct 17, 2022

ST PHARM NewsST PHARM, Frost & Sullivan Best Practices Virtual Awards CeremonyAug 17, 2022

ST PHARM NewsST PHARM, FDA cGMP certification for oligo plant in Korea, for the first time in AsiaAug 2, 2022

ST PHARM NewsST PHARM 'STP1002' Preclinical Result EJC PublishedJul 19, 2022

ST PHARM NewsST PHARM Acquired EcoVadis Silver Grade CertificationJul 11, 2022

ST PHARM NewsST PHARM Announces HIV-1 / AIDS Treatment Drug 'STP0404' Phase 1 Clinical Trial Results 'Positive and Safe'Jul 6, 2022

ST PHARM NewsST PHARM, Awarded 2022 Asia-Pacific Oligonucleotide CDMO Campany by Frost & SullivanMay 2, 2022

1of2